BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 16503123)

  • 1. Genetics of familial and sporadic amyotrophic lateral sclerosis.
    Gros-Louis F; Gaspar C; Rouleau GA
    Biochim Biophys Acta; 2006; 1762(11-12):956-72. PubMed ID: 16503123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
    Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
    Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALS pathogenesis: recent insights from genetics and mouse models.
    Swarup V; Julien JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):363-9. PubMed ID: 20728492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic mouse models of amyotrophic lateral sclerosis.
    Julien JP; Kriz J
    Biochim Biophys Acta; 2006; 1762(11-12):1013-24. PubMed ID: 16675207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of familial Amyotrophic lateral sclerosis.
    Ticozzi N; Tiloca C; Morelli C; Colombrita C; Poletti B; Doretti A; Maderna L; Messina S; Ratti A; Silani V
    Arch Ital Biol; 2011 Mar; 149(1):65-82. PubMed ID: 21412717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genetics of amyotrophic lateral sclerosis.
    Kuźma-Kozakiewicz M; Kwieciński H
    Neurol Neurochir Pol; 2009; 43(6):538-49. PubMed ID: 20054757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of amyotrophic lateral sclerosis.
    Robberecht W
    J Neurol; 2000 Dec; 247 Suppl 6():VI/2-6. PubMed ID: 19714405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive spinal axonal degeneration and slowness in ALS2-deficient mice.
    Yamanaka K; Miller TM; McAlonis-Downes M; Chun SJ; Cleveland DW
    Ann Neurol; 2006 Jul; 60(1):95-104. PubMed ID: 16802286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of amyotrophic lateral sclerosis.
    Robberecht W
    J Neurol; 2000 Dec; 247():2-6. PubMed ID: 11200702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene mutations in familial amyotrophic lateral sclerosis].
    Oda M; Izumi Y; Kaji R
    Brain Nerve; 2011 Feb; 63(2):165-70. PubMed ID: 21301041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: application to amyotrophic lateral sclerosis.
    Kudo LC; Parfenova L; Vi N; Lau K; Pomakian J; Valdmanis P; Rouleau GA; Vinters HV; Wiedau-Pazos M; Karsten SL
    Hum Mol Genet; 2010 Aug; 19(16):3233-53. PubMed ID: 20530642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in amyotrophic lateral sclerosis, clues from the SOD1 mouse.
    Spalloni A; Longone P
    Neurosci Biobehav Rev; 2016 Jan; 60():12-25. PubMed ID: 26602023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of TDP-43 abnormalities in mutant SOD1 transgenic mice shows disparity with ALS.
    Robertson J; Sanelli T; Xiao S; Yang W; Horne P; Hammond R; Pioro EP; Strong MJ
    Neurosci Lett; 2007 Jun; 420(2):128-32. PubMed ID: 17543992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic mechanisms in familial amyotrophic lateral sclerosis due to mutation of Cu, Zn superoxide dismutase.
    Gurney ME; Cutting FB; Zhai P; Andrus PK; Hall ED
    Pathol Biol (Paris); 1996 Jan; 44(1):51-6. PubMed ID: 8734301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant SOD1 mediated pathogenesis of Amyotrophic Lateral Sclerosis.
    Kaur SJ; McKeown SR; Rashid S
    Gene; 2016 Feb; 577(2):109-18. PubMed ID: 26657039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
    J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis as a complex genetic disease.
    Simpson CL; Al-Chalabi A
    Biochim Biophys Acta; 2006; 1762(11-12):973-85. PubMed ID: 16973338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.